Phase II Trial of Sequential Chemotherapy and Radiotherapy for AIDS-Related Primary Central Nervous System Lymphoma

NCT00000801 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

33

Enrollment

NIH

Sponsor class

Conditions

Lymphoma, Non-Hodgkin
HIV Infections

Interventions

DRUG: Filgrastim
DRUG: Vincristine sulfate
DRUG: Doxorubicin hydrochloride
DRUG: Cyclophosphamide
DRUG: Cytarabine
DRUG: Dexamethasone

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)